Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Contineum Therapeutics Stock

Q: Can you buy Contineum Therapeutics stock?

You can no longer buy Contineum Therapeuticsstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

contineum-tx.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $133.61MM

Contineum is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology indications with high unmet need.

Learn more about Contineum Therapeutics IPO

Enterprise Value

Access valuation and stock price for companies like Contineum Therapeutics before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Contineum Therapeutics stock FAQs

Can you buy Contineum Therapeutics stock?

You can no longer buy Contineum Therapeutics stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Contineum Therapeutics stock?

To invest in a private company like Contineum Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Contineum Therapeutics stock?

You can no longer sell stock of Contineum Therapeutics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Contineum Therapeutics stock?

If you hold private company shares of Contineum Therapeutics - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Contineum Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Contineum Therapeutics a public company?

No, Contineum Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Contineum Therapeutics’ stock ticker symbol?

The ticker symbol of Contineum Therapeutics is CTNM.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Pharmaceuticals Technology 04/18/2023

Pipeline Therapeutics and Janssen partner for neuroscience therapy

"Pipeline Therapeutics and Janssen Pharmaceutical have partnered to develop PIPE-307, a potential treatment for disorders of the nervous system. Janssen will receive an exclusive global licence for the research, development and commercialisation of PIPE-307, while Pipeline will have the right to advance the therapy into a Phase II clinical trial. Janssen will make an upfront payment of $50m to Pipeline and Pipeline will receive $1bn in milestones, along with royalty payments.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.